KK
Kandasamy Kumaravadivel
About Kandasamy Kumaravadivel
Data last updated:
Kandasamy Kumaravadivel is a Managing Director at Kgms Energy Private Limited (since 2022), Director at Nanmei Pharmaceuticals Private Limited (since 2026) and Director at Tracell Medtech Private Limited (since 2026). The companies operate in Energy and Power. The largest current company by reported revenue is Kgms Energy Private Limited at ₹2.96 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 27 Jan 2022 | 2022 | ₹2.96 Cr (FY 2024) | Active | |
| Director | 08 Jul 2026 | 2026 | Active | ||
| Director | 20 Jan 2026 | 2026 | Active |
Board colleagues of Kandasamy Kumaravadivel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kumaravadivel Sasikala | 09481364 | Kgms Energy Private Limited | Director |
| Manisankari Kumaravadivel | 11495906 | Nanmei Pharmaceuticals Private Limited , Tracell Medtech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kandasamy Kumaravadivel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kandasamy Kumaravadivel
Kandasamy Kumaravadivel currently holds 3 directorships: Kgms Energy Private Limited (Managing Director, since 27 Jan 2022, revenue ₹2.96 Cr (FY 2024)); Nanmei Pharmaceuticals Private Limited (Director, since 08 Jul 2026); Tracell Medtech Private Limited (Director, since 20 Jan 2026).
Kandasamy Kumaravadivel was first appointed on 27 Jan 2022 as Managing Director at Kgms Energy Private Limited. The most recent appointment on record is 08 Jul 2026 at Nanmei Pharmaceuticals Private Limited.
The current boards of Kandasamy Kumaravadivel's companies include Kumaravadivel Sasikala (Kgms Energy Private Limited), Manisankari Kumaravadivel (Nanmei Pharmaceuticals Private Limited).